Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Cathie Wood's ARK ETF adjusts holdings with key stock trades

Published 27/07/2024, 10:04 am
ARKG
-
ARKQ
-
ARKK
-

Cathie Wood's ARK ETF has published their daily trades for Friday, July 26th, 2024, with a mix of buy and sell actions that reflect the fund's ongoing strategy adjustments. The most significant transaction of the day involved the sale of CAREDX INC (NASDAQ:CDNA) shares, with ARK's Genomic Revolution ETF (ARKG) offloading 41,391 shares, resulting in a total value of $781,048.

Following this, ARK continued to reduce its stake in TELADOC HEALTH INC (NYSE:TDOC), selling 10,323 shares through two of its ETFs, ARKK and ARKG, for a combined value of $95,487. This move is consistent with ARK's recent trend of trimming its position in TDOC, which has been observed over the past week.

In a smaller transaction, ARK parted with 8611 shares of VELO3D INC (NYSE:VLD) across its ARKQ and ARKX ETFs, totaling $24,627. The sale of UIPATH INC (NYSE:PATH) was also on the agenda, with 582 shares sold through ARKG for a modest $7,100.

On the buying side, ARK's Genomic Revolution ETF (ARKG) picked up 3,045 shares of TEMPUS AI INC (NYSE:TEM), a company focused on artificial intelligence in healthcare, for a value of $121,860. This purchase adds to the significant investment ARK made in TEMPUS AI just the day before, indicating a growing interest in the company's prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.